Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 9.80 | 0.85 | 11.38 |
| 6M | 6.66 | 1.78 | 9.62 |
| 1Y | 13.22 | 5.15 | 17.07 |
| 3Y | 24.85 | 14.17 | 117.52 |
Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹901 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.27. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Dhaval Shah holds B.Com, CFA, MMS - Finance (Post graduation). He has worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| Tata India Pharma & HealthCare Fund Growth | 2 | 1325.19 CR | 2.21 |
| Nippon India Pharma Fund Growth | 4 | 8365.4 CR | 2.32 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Growth | 2 | 900.87 CR | 2.27 |
| UTI Healthcare Fund Growth | 3 | 1143.58 CR | 2.3 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 5 | 6668.95 CR | 2.41 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundTata India Pharma & HealthCare Fund Growth | 7.5335 | 90.3594 |
| This FundNippon India Pharma Fund Growth | 9.9047 | 90.8171 |
| This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth | 13.2184 | 94.5962 |
| This FundUTI Healthcare Fund Growth | 13.2403 | 105.4054 |
| This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 10.8811 | 112.1889 |